Chicago-based start-up Tempus has raised $200m from investors including Novo Holdings and Revolution Growth, and gained a valuation of $3.1bn. Tempus, created by Groupon co-founder Eric Lefkofsky, gathers and analyses clinical and molecular information for a database that will enable more precise health care. The company is also working with the US Food and Drug Administration to develop an app called HealthTap which allows users to track their blood sugar levels in real time.
Chicago-based start-up Tempus has raised $200m from investors including Novo Holdings and Revolution Growth, and gained a valuation of $3.1bn. Tempus, created by Groupon co-founder Eric Lefkofsky, gathers and analyses clinical and molecular information for a database that will enable more precise health care. The company said the latest investment will enable it to expand its focus from cancer to conditions including depression and diabetes.